Benzinga's Top Upgrades

Analysts at Goldman Sachs upgraded Vertex Pharmaceuticals VRTX from Neutral to Buy. The target price for Vertex Pharmaceuticals has been raised from $109 to $131. Vertex Pharmaceuticals' shares closed at $95.04 on Friday. Analysts at KeyBanc upgraded Matrix Service Company MTRX from Hold to Buy. The target price for Matrix Service is set to $29. Matrix Service's shares closed at $24.01 on Friday. Analysts at Oppenheimer upgraded L-3 Communications Holdings LLL from Market Perform to Outperform. The target price for L-3 Communications is set to $128. L-3 Communications' shares closed at $112.06 on Friday. Jefferies upgraded Infinera INFN from Hold to Buy. Infinera's shares closed at $10.33 on Friday.